Skip to main content
SpringerLink
Log in

Vitamins, Antioxidants and Endothelial Function in Coronary Artery Disease

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 1998;101:731–736.

    Google Scholar 

  2. Al Suwaidi J, Hamasaki S, Higano S, et al. Long-term followup of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948–954.

    Google Scholar 

  3. Neunteufl T, Priglinger U, Heher S, et al. Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. J Am Coll Cardiol 2000;35:277–283.

    Google Scholar 

  4. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilaator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899–1906.

    Google Scholar 

  5. Xia Y, et al. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci 1996;93:6770–6774.

    Google Scholar 

  6. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141–1148.

    Google Scholar 

  7. Rajagopalan S, Kurz S, Münzel T, et al. Antiotensin II-mediated hypertension in the rat increases vascular superoxide production via membraneNADH/NADPHoxidase activation. J Clin Invest 1996;96:1513–1519.

    Google Scholar 

  8. Warnholtz A, Nickenig G, Schulz E, et al. Increased NADHoxidase-mediated superoxide production in the early stages of atherosclerosis: Evidence for the involvement of the renin-angiotensin system. Circulation 1999;99:2027–y2033.

    Google Scholar 

  9. Stralin P, et al. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterisclerosis Thromb Vasc Biol 1995;15:2032–2036.

    Google Scholar 

  10. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996;93:1107–1113.

    Google Scholar 

  11. Motoyoma T, Kawano H, Kugiyama K, et al. Endotheliumdependent vasodilation in the brachial artery is impaired in smokers: Effect of vitamin C. Am J Physiol 1997;273:1644–1650.

    Google Scholar 

  12. Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function in patients with chronic heart failure. Circulation 1998;97:363–368.

    Google Scholar 

  13. Duffy SJ, Gokce N, Holbrook M, et al. Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. Am J Physiol 2001;279:528–534.

    Google Scholar 

  14. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998;97:2222–2229.

    Google Scholar 

  15. Ting, HH, Timimi FK, Boles KS, et al. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin dependent diabetes mellitus. J Clin Invest 1996;97:22–28.

    Google Scholar 

  16. Timimi FK, Ting HH, Haley, et al. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998;31:552–557.

    Google Scholar 

  17. Beckmann JA, Goldfine AB, Gordon MB, Craefer MA. Ascorbate restores endothelium-dependent vasodilation impaired by acute hypergglycemia in humans. Circulation 2001;103:1618–1623.

    Google Scholar 

  18. Ellis GR, Anderson RA, Lang D, et al. Neutrophil superoxide anion-generating capacity, endothelial function and oxidative sress in chronic heart failure: Effects of shortand long-term vitamin C therapy. J Am Coll Cardiol 2000;36:1474–1482.

    Google Scholar 

  19. Solzbach U, Hornig B, Jeserich M, Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in patients with essential hypertension. Circulation 1997;96:1513–1519.

    Google Scholar 

  20. Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, et al. Coronary heart disease in smokers. Vitamin C restores coronary microcirculatory function. Circulation 2000;102:1233–1238.

    Google Scholar 

  21. Jackson TS, Xu A, Vita JA, Keaney JF. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circulation Research 1998;83:916–922.

    Google Scholar 

  22. Duffy SJ, Gokce N, Holbrook M, et al. Treatment of hypertension with ascorbic acid. Lancet 1999;354:2048–2049.

    Google Scholar 

  23. Langlois M, Duprez D, Delanghe J, De Buyzere M, Clement DL. Serum vitaminCconcentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 2001;103:1863–1868.

    Google Scholar 

  24. Khaw K-T, Bingham S, Luben R, Wareham N, Oakes S, Day N. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: A prospective population study. Lancet 2001;357:657–663.

    Google Scholar 

  25. Huang A, et al. JBC 2000;275:17399–17406.

    Google Scholar 

  26. Pritchard KA, Groszek L, Smalley DM, et al. Native lowdensity lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 1995;77:510–518.

    Google Scholar 

  27. Heitzer T, Brockhoff C, Mayer B, et al. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: Evidence for dysfunctional nitric oxide synthase. Circulation Research 2000;86:36–41.

    Google Scholar 

  28. Stroes E, Kastelein J, Cosentino F, et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 1997;99:41–46.

    Google Scholar 

  29. Tiefenbacher CP, Bleeke T, Vahl C, et al. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation 2000;102:2172–2176.

    Google Scholar 

  30. Ueda S, Matsuoka H, Miyazaki H, Usui M, Okuda S, Imaizumi T. Tetrahydrobiopterin restores endothelial function in long-term smokers. JAmColl Cardiol 1999;35:71–75.

    Google Scholar 

  31. Anderson T, Meredith I, Yeung A, Frei B, Selwyn AP, Ganz P. The effect of cholesterol lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;332:488–493.

    Google Scholar 

  32. Kinlay S, Fang JC, Hikita H, et al. Plasma tocopherol and coronary endothelium-dependent vasodilator function. Circulation 1999;100:219–221.

    Google Scholar 

  33. Evans M, Anderson RA, Graham J, et al. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. Circulation 2000;101:1773–1778.

    Google Scholar 

  34. Gilligan DM, Sack MN, Guetta V, et al. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J Am Coll Cardiol 1994;24:1611–1617.

    Google Scholar 

  35. Heitzer T, Yla Herttuala S, Wild E, Uoma J, Drexler H. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both. J Am Coll Cardiol 1999;33(2):499–505.

    Google Scholar 

  36. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, Ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145–153.

    Google Scholar 

  37. Stein JH, Keevil JG, Wiebe DA, et al. Purple grape juice improves endothelial function and reduces the susceptibility of LDL-cholesterol to oxidation in patients with coronary artery disease. Circulation 1999;100:1050–1055.

    Google Scholar 

  38. Flesch M, Schwarz A, Boehm M. Divergent effects of red and white wine on endothelium-dependent relaxation of human coronary arteries. Circulation 1997;96:I-341(abstract).

    Google Scholar 

  39. Renaud S, De Lorgeril M. Wine, alcohol, platelets and the french paradox for coronary heart disease. Lancet 1992;339:1523–1526.

    Google Scholar 

  40. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbitiy in patients with left ventricular dysfunction after myocardial infarctions: Results of the survival and ventricular enlargement trial. N Eng J Med 1992:327:669–677.

    Google Scholar 

  41. Yusuf S, Pepine CJ, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992;340:1173–1178.

    Google Scholar 

  42. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbitiy of survivors of acute mycardial infarction with clinical evidence of heart failure. Lancet 1993;342:821–828.

    Google Scholar 

  43. Mancini GBF, Henry GC, Macaya C, et al. Angiotensinconverting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996;94:258–265.

    Google Scholar 

  44. Hornig B, Kohler C, Drexler H. Role of bradykinin in mediating vascular effects of ACE-inhibitors in humans. Circulation 1997;95:1115–1118.

    Google Scholar 

  45. Hornig B, Arakawa N, Hausmann D, Drexler H. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998;98(25):2442–2448.

    Google Scholar 

  46. Anderson TJ, Elstein E, Haber H, Charbonneau F. Comparative study of ACE-inhibition, angiotensin-II antagonism and calcium-channel blockade on flow-mediated vasodilation in patients with coronary artery disease (BANFF-study). J Am Coll Cardiol 1999;35:60–66.

    Google Scholar 

  47. Pellacani A, Brunner HR, Nussberger J. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. Clin Sci 1994;87:567–574.

    Google Scholar 

  48. Groves P, Kurz S, Just H, Drexler H. Role of endogenous bradykinin in human coronary vasomotor control. Circulation 1995;92:3424–3430.

    Google Scholar 

  49. Hornig B, Landmesser U, Kohler C, et al. Comparative effect of ACE-inhibition and angiotensin II-type 1-receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease-Role of superoxide dismutase. Circulation 2001;103:799–805.

    Google Scholar 

  50. Prasad A, Tupas-habib T, Schenke WH, et al. Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclöerosis. Circulation 2000;101:2349.

    Google Scholar 

  51. Cheetham C, Collis J, O'Driscoll G, Stanton K, Taylor R, Green D. Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. J Am Coll Cardiol 2000;36:1461–1466.

    Google Scholar 

  52. O'Discroll G, Green D, Taylor RR. Simvastatin, an HMGcoenzyme a reductase inhibitor, improves endothelial function within 1 month. Circulation 1997;95:1126–1131.

    Google Scholar 

  53. Laufs U, Fata VL, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998;97:1129–1135.

    Google Scholar 

  54. Nickening G, Bäumer AT, Temur Y, Kebben D, Jockelhovel F, Böhm M. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation 1999;100:2131–2134.

    Google Scholar 

  55. Gould KL, Martucci JP, Goldberg DI, et al. Short-term cholersterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipirydamol in patients with coronary artery disease-Apotential noninvasive marker of healing coronary endothelium. Circulation 1994;89:1530–1538.

    Google Scholar 

  56. Mostaza JM, Gomez MV, Gallardo F, et al. Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels. J Am Coll Cardiol 2000;35:76–82.

    Google Scholar 

  57. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease, Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383–1389.

    Google Scholar 

  58. Sacks FM, Pfeffer MA, Lemuel AM, et al. The effect of Pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001–1009.

    Google Scholar 

  59. The Long-Term Invervention with Pravastatin in Ischemic Heart Failure (LIPID) Study Group. Prevention of cardiovascular events and death with Pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;39:1349–1357.

    Google Scholar 

  60. Pitt B, Waters D, Brown WV, et al. Aggressive lipidlowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med 1999;341:70–76.

    Google Scholar 

  61. Rieder MJ, Carmona R, Krieger JE, Pitchard KA, Jr, Greene AS. Supression of angiotensin-converting enzyme expression by shear stress. Circ Res 1997;80:312–319.

    Google Scholar 

  62. Heitzer T, Just H, Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996;94:6–9.

    Google Scholar 

  63. Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endotheliumdependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 1997;95:2617–2622.

    Google Scholar 

  64. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbitiy in patients with left ventricular dysfunction after myocardial infarctions: Results of the survival and ventricular enlargement trial. N Eng J Med 1992:327:669–677.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover, Germany

    Burkhard Hornig

Authors
  1. Burkhard Hornig
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hornig, B. Vitamins, Antioxidants and Endothelial Function in Coronary Artery Disease. Cardiovasc Drugs Ther 16, 401–409 (2002). https://doi.org/10.1023/A:1022182201534

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022182201534

Keywords

Search

Navigation